Lagrange A - Search Results

1

Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In Vitro.

Velier M, Simoncini S, Abellan M, Francois P, Eap S, Lagrange A, Bertrand B, Daumas A, Granel B, Delorme B, Dignat George F, Magalon J, Sabatier F. Velier M, et al. Among authors: lagrange a. J Clin Med. 2019 Nov 14;8(11):1979. doi: 10.3390/jcm8111979. J Clin Med. 2019. PMID: 31739569 Free PMC article.

2

Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells.

Viau S, Eap S, Chabrand L, Lagrange A, Delorme B. Viau S, et al. Among authors: lagrange a. Transfusion. 2019 Mar;59(3):1069-1079. doi: 10.1111/trf.15205. Epub 2019 Feb 21. Transfusion. 2019. PMID: 30793328

3

A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells.

Viau S, Lagrange A, Chabrand L, Lorant J, Charrier M, Rouger K, Alvarez I, Eap S, Delorme B. Viau S, et al. Among authors: lagrange a. Cytotherapy. 2019 Jul;21(7):738-754. doi: 10.1016/j.jcyt.2019.04.053. Epub 2019 May 24. Cytotherapy. 2019. PMID: 31133491

4

Keratinocyte-melanocyte co-cultures and pigmented reconstructed human epidermis: models to study modulation of melanogenesis.

Régnier M, Duval C, Galey JB, Philippe M, Lagrange A, Tuloup R, Schmidt R. Régnier M, et al. Among authors: lagrange a. Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):969-80. Cell Mol Biol (Noisy-le-grand). 1999. PMID: 10644001

5

Exclusive Oral Antibiotic Treatment for Hospitalized Community-Acquired Pneumonia: A Post-Hoc Analysis of a Randomized Clinical Trial.

Dinh A, Duran C, Ropers J, Bouchand F, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Among authors: lagrange a. Clin Microbiol Infect. 2024 May 9:S1198-743X(24)00237-4. doi: 10.1016/j.cmi.2024.05.003. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 38734138

6

Characterization of a Molecularly Distinct Subset of Oncocytic Pleomorphic Adenomas/Myoepitheliomas Harboring Recurrent ZBTB47-AS1::PLAG1 Gene Fusion.

Alsugair Z, Perrot J, Descotes F, Lopez J, Champagnac A, Pissaloux D, Castain C, Onea M, Céruse P, Philouze P, Lépine C, Lanic MD, Laé M, Costes-Martineau V, Benzerdjeb N; and REFCOR Members. Alsugair Z, et al. Am J Surg Pathol. 2024 May 1;48(5):551-561. doi: 10.1097/PAS.0000000000002206. Epub 2024 Mar 18. Am J Surg Pathol. 2024. PMID: 38497430

7

Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.

Dalens L, Niogret J, Richard C, Chevrier S, Foucher P, Coudert B, Lagrange A, Favier L, Westeel V, Kim S, Adotevi O, Chapusot C, Martin L, Arnould L, Kaderbhai CG, Boidot R. Dalens L, et al. Among authors: lagrange a. Mol Cancer. 2023 Jul 29;22(1):120. doi: 10.1186/s12943-023-01829-4. Mol Cancer. 2023. PMID: 37516818 Free PMC article.

8

Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.

Dalens L, Lecuelle J, Favier L, Fraisse C, Lagrange A, Kaderbhai C, Boidot R, Chevrier S, Mananet H, Derangère V, Truntzer C, Ghiringhelli F. Dalens L, et al. Among authors: lagrange a. Int J Mol Sci. 2023 Apr 20;24(8):7592. doi: 10.3390/ijms24087592. Int J Mol Sci. 2023. PMID: 37108755 Free PMC article.

9

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Adotévi O, Vernerey D, Jacoulet P, Meurisse A, Laheurte C, Almotlak H, Jacquin M, Kaulek V, Boullerot L, Malfroy M, Orillard E, Eberst G, Lagrange A, Favier L, Gainet-Brun M, Doucet L, Teixeira L, Ghrieb Z, Clairet AL, Guillaume Y, Kroemer M, Hocquet D, Moltenis M, Limat S, Quoix E, Mascaux C, Debieuvre D, Fagnoni-Legat C, Borg C, Westeel V. Adotévi O, et al. Among authors: lagrange a. J Clin Oncol. 2023 Jan 10;41(2):373-384. doi: 10.1200/JCO.22.00096. Epub 2022 Sep 7. J Clin Oncol. 2023. PMID: 36070539 Clinical Trial.

10

Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort.

Tankere P, Boidot R, Bonniaud P, Zouak A, Foucher P, Milliere A, Bertaut A, Favier L, Lagrange A, Ghiringhelli F, Kaderbhai CG, Fraisse C. Tankere P, et al. Among authors: lagrange a. J Thorac Dis. 2022 Jun;14(6):2034-2044. doi: 10.21037/jtd-21-1924. J Thorac Dis. 2022. PMID: 35813741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page